5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-N-methylthiophene-2-sulfonamide;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-piperidin-1-ylpiperidin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-piperidin-1-ylpyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;molecular hydrogen

C86H131N33O2S2 — CID 158590385

IUPAC5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-N-methylthiophene-2-sulfonamide;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-piperidin-1-ylpiperidin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-piperidin-1-ylpyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;molecular hydrogen
SMILESCCc1cnc(N2CCC(N3CCCCC3)CC2)nc1Nc1cc(C2CC2)[nH]n1.CCc1cnc(N2CCCCC2)nc1Nc1cc(C2CC2)[nH]n1.CCc1cnc(N2CCN(C)CC2)nc1Nc1cc(C2CC2)[nH]n1.CN1CCN(c2nccc(Nc3cc(C4CC4)[nH]n3)n2)CC1.CNS(=O)(=O)c1ccc(-c2nccc(Nc3cc(C4CC4)[nH]n3)n2)s1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C22H33N7.C17H25N7.C17H24N6.C15H21N7.C15H16N6O2S2.6H2/c1-2-16-15-23-22(25-21(16)24-20-14-19(26-27-20)17-6-7-17)29-12-8-18(9-13-29)28-10-4-3-5-11-28;1-3-12-11-18-17(24-8-6-23(2)7-9-24)20-16(12)19-15-10-14(21-22-15)13-4-5-13;1-2-12-11-18-17(23-8-4-3-5-9-23)20-16(12)19-15-10-14(21-22-15)13-6-7-13;1-21-6-8-22(9-7-21)15-16-5-4-13(18-15)17-14-10-12(19-20-14)11-2-3-11;1-16-25(22,23)14-5-4-11(24-14)15-17-7-6-12(19-15)18-13-8-10(20-21-13)9-2-3-9;;;;;;/h14-15,17-18H,2-13H2,1H3,(H2,23,24,25,26,27);10-11,13H,3-9H2,1-2H3,(H2,18,19,20,21,22);10-11,13H,2-9H2,1H3,(H2,18,19,20,21,22);4-5,10-11H,2-3,6-9H2,1H3,(H2,16,17,18,19,20);4-9,16H,2-3H2,1H3,(H2,17,18,19,20,21);6*1H
InChIKeyHUJIJGQKIGFXMQ-UHFFFAOYSA-N
MW1723.36 g/mol
LogP14.85
Rot. Bonds26

About 5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-N-methylthiophene-2-sulfonamide;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-piperidin-1-ylpiperidin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-piperidin-1-ylpyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;molecular hydrogen

5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-N-methylthiophene-2-sulfonamide;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-piperidin-1-ylpiperidin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-piperidin-1-ylpyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;molecular hydrogen (PubChem CID 158590385) has the molecular formula C86H131N33O2S2 and a molecular weight of 1723.36 g/mol. Its IUPAC name is 5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-N-methylthiophene-2-sulfonamide;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-piperidin-1-ylpiperidin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-piperidin-1-ylpyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;molecular hydrogen.

Molecular Properties

Compound Name5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-N-methylthiophene-2-sulfonamide;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-piperidin-1-ylpiperidin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-piperidin-1-ylpyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;molecular hydrogen
PubChem CID158590385
Molecular FormulaC86H131N33O2S2
Molecular Weight1723.36 g/mol
Exact Mass1722.06
IUPAC Name5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-N-methylthiophene-2-sulfonamide;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-piperidin-1-ylpiperidin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-piperidin-1-ylpyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;molecular hydrogen
SMILESCCc1cnc(N2CCC(N3CCCCC3)CC2)nc1Nc1cc(C2CC2)[nH]n1.CCc1cnc(N2CCCCC2)nc1Nc1cc(C2CC2)[nH]n1.CCc1cnc(N2CCN(C)CC2)nc1Nc1cc(C2CC2)[nH]n1.CN1CCN(c2nccc(Nc3cc(C4CC4)[nH]n3)n2)CC1.CNS(=O)(=O)c1ccc(-c2nccc(Nc3cc(C4CC4)[nH]n3)n2)s1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C22H33N7.C17H25N7.C17H24N6.C15H21N7.C15H16N6O2S2.6H2/c1-2-16-15-23-22(25-21(16)24-20-14-19(26-27-20)17-6-7-17)29-12-8-18(9-13-29)28-10-4-3-5-11-28;1-3-12-11-18-17(24-8-6-23(2)7-9-24)20-16(12)19-15-10-14(21-22-15)13-4-5-13;1-2-12-11-18-17(23-8-4-3-5-9-23)20-16(12)19-15-10-14(21-22-15)13-6-7-13;1-21-6-8-22(9-7-21)15-16-5-4-13(18-15)17-14-10-12(19-20-14)11-2-3-11;1-16-25(22,23)14-5-4-11(24-14)15-17-7-6-12(19-15)18-13-8-10(20-21-13)9-2-3-9;;;;;;/h14-15,17-18H,2-13H2,1H3,(H2,23,24,25,26,27);10-11,13H,3-9H2,1-2H3,(H2,18,19,20,21,22);10-11,13H,2-9H2,1H3,(H2,18,19,20,21,22);4-5,10-11H,2-3,6-9H2,1H3,(H2,16,17,18,19,20);4-9,16H,2-3H2,1H3,(H2,17,18,19,20,21);6*1H
InChIKeyHUJIJGQKIGFXMQ-UHFFFAOYSA-N
XLogP14.85
TPSA401.30 Ų
H-Bond Donors11
H-Bond Acceptors30
Rotatable Bonds26
Heavy Atoms123
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001723.36
LogP ≤ 514.85
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1030

Analyze 5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-N-methylthiophene-2-sulfonamide;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-piperidin-1-ylpiperidin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-piperidin-1-ylpyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;molecular hydrogen with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-N-methylthiophene-2-sulfonamide;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-piperidin-1-ylpiperidin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-piperidin-1-ylpyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;molecular hydrogen?
The IUPAC name of 5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-N-methylthiophene-2-sulfonamide;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-piperidin-1-ylpiperidin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-piperidin-1-ylpyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;molecular hydrogen (CID 158590385) is 5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-N-methylthiophene-2-sulfonamide;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-piperidin-1-ylpiperidin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-piperidin-1-ylpyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;molecular hydrogen.
What is the SMILES notation for 5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-N-methylthiophene-2-sulfonamide;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-piperidin-1-ylpiperidin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-piperidin-1-ylpyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;molecular hydrogen?
The canonical SMILES for 5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-N-methylthiophene-2-sulfonamide;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-piperidin-1-ylpiperidin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-piperidin-1-ylpyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;molecular hydrogen is CCc1cnc(N2CCC(N3CCCCC3)CC2)nc1Nc1cc(C2CC2)[nH]n1.CCc1cnc(N2CCCCC2)nc1Nc1cc(C2CC2)[nH]n1.CCc1cnc(N2CCN(C)CC2)nc1Nc1cc(C2CC2)[nH]n1.CN1CCN(c2nccc(Nc3cc(C4CC4)[nH]n3)n2)CC1.CNS(=O)(=O)c1ccc(-c2nccc(Nc3cc(C4CC4)[nH]n3)n2)s1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].
What is the InChIKey of 5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-N-methylthiophene-2-sulfonamide;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-piperidin-1-ylpiperidin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-piperidin-1-ylpyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;molecular hydrogen?
The InChIKey is HUJIJGQKIGFXMQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H33N7.C17H25N7.C17H24N6.C15H21N7.C15H16N6O2S2.6H2/c1-2-16-15-23-22(25-21(16)24-20-14-19(26-27-20)17-6-7-17)29-12-8-18(9-13-29)28-10-4-3-5-11-28;1-3-12-11-18-17(24-8-6-23(2)7-9-24)20-16(12)19-15-10-14(21-22-15)13-4-5-13;1-2-12-11-18-17(23-8-4-3-5-9-23)20-16(12)19-15-10-14(21-22-15)13-6-7-13;1-21-6-8-22(9-7-21)15-16-5-4-13(18-15)17-14-10-12(19-20-14)11-2-3-11;1-16-25(22,23)14-5-4-11(24-14)15-17-7-6-12(19-15)18-13-8-10(20-21-13)9-2-3-9;;;;;;/h14-15,17-18H,2-13H2,1H3,(H2,23,24,25,26,27);10-11,13H,3-9H2,1-2H3,(H2,18,19,20,21,22);10-11,13H,2-9H2,1H3,(H2,18,19,20,21,22);4-5,10-11H,2-3,6-9H2,1H3,(H2,16,17,18,19,20);4-9,16H,2-3H2,1H3,(H2,17,18,19,20,21);6*1H.
What are the key properties of 5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-N-methylthiophene-2-sulfonamide;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-piperidin-1-ylpiperidin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-piperidin-1-ylpyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;molecular hydrogen?
5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-N-methylthiophene-2-sulfonamide;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-piperidin-1-ylpiperidin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-piperidin-1-ylpyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;molecular hydrogen has a molecular weight of 1723.36 g/mol, XLogP of 14.85, 26 rotatable bonds, 11 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-N-methylthiophene-2-sulfonamide;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-(4-piperidin-1-ylpiperidin-1-yl)pyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-5-ethyl-2-piperidin-1-ylpyrimidin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(4-methylpiperazin-1-yl)pyrimidin-4-amine;molecular hydrogen is sourced from PubChem (CID 158590385), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).